Skip to content

Concept of risk communication and effects of APOE4 disclosure.

Concept of risk communication and effects of APOE4 disclosure. - CREAD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034113
Enrollment
70
Registered
2026-01-19
Start date
2025-04-28
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F04

Interventions

Group 1: This is a longitudinal study over a period of 12 months with the aim of improving the concept of risk reporting based on the ApoE gene status and investigating the needs of the target group.

Sponsors

Klinik und Poliklinik für Psychiatrie und Psychotherapie Uniklinik Köln (AöR)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age at least 18 years - Informed, written consent of the study participants - sufficient knowledge of German to answer the questionnaires - previous participation in the INSPIRATION study (DRKS00020767) or lipid study (DRKS00031261) with determination of ApoE gene status - heterozygous or homozygous ApoE-e4 gene status

Exclusion criteria

Exclusion criteria: - Diagnosis of dementia - MMSE ¬= 27 points - moderate to severe depressive disorder - anxiety disorder - HADS score > 10 points - Acute suicidal tendencies -deficit of german language skills

Design outcomes

Primary

MeasureTime frame
This study examines how people who find out their personal dementia risk profile deal with this risk knowledge. To this end, a standardized methodology is being developed to determine how communication should take place before, during and after the disclosure of genetic status. A quantitative survey will be used to collect information on the effects of disclosing the individual risk on the test persons and what their needs are. The aim of the work is to develop a standardized information process for this risk group. All target variables are collected using questionnaires.

Countries

Germany

Contacts

Public ContactAyda Rostamzadeh

Kölner Alzheimer Präventionszentrum, Uniklinik Köln

ayda.rostamzadeh@uk-koeln.de0221 478-78999

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026